The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma
NCT01611012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115
Last updated 2014-07-03
Summary
The purpose of this study is to determine the type and degree of inflammatory parameters in peripheral blood of asthma patients compared to analysis of induced sputum.
115 asthma patients visiting the outpatient clinic of the University Medical Center will be included. Blood samples are obtained and sputum induction is performed.
Hypothesis: in asthma the analysis of type and degree of inflammation in peripheral blood by changes in phenotypes of leukocytes is at least as reliable as analysis of cells obtained from induced sputum
Conditions
Sponsors & Collaborators
-
Prof. Jan-Willem Lammers MD PhD
lead OTHER
Principal Investigators
-
Jan-Willem Lammers, MD, PhD · Respiratory Department, UMC Utrecht
-
Leo Koenderman, M.D. PhD · Respiratory Department, UMC Utrecht
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162 ·Status: COMPLETED
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Molecular Mechanism of Asthma
NCT00180726 ·Status: WITHDRAWN ·Phase: NA
-
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
NCT07011394 ·Status: RECRUITING
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Cell Distribution in Induced Sputum in Patients With Asthma
NCT01543516 ·Status: COMPLETED
-
Endotoxin and Bronchial Inflammation in Asthma
NCT00005550 ·Status: COMPLETED
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2
NCT01224951 ·Status: UNKNOWN ·Phase: NA
-
SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training
NCT04395937 ·Status: RECRUITING ·Phase: NA
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Inflammatory, Functional and Image Composite Measure to Define Asthma Control
NCT00597064 ·Status: UNKNOWN ·Phase: PHASE4
-
The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment
NCT03460106 ·Status: UNKNOWN
-
Factors Involved in Asthma and Airway Inflammation
NCT00001887 ·Status: COMPLETED
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment
NCT02233231 ·Status: COMPLETED ·Phase: PHASE4
-
Airway Inflammation and Disease Burden in Asthmatic Smokers
NCT02833727 ·Status: UNKNOWN
-
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991 ·Status: COMPLETED
-
Asthma: Phenotyping Exacerbations 3
NCT05446090 ·Status: UNKNOWN
-
Some Biomarkers in Bronchial Asthma in Children
NCT04175093 ·Status: UNKNOWN
-
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
NCT00838552 ·Status: COMPLETED
-
Inflammation and Corticosteroid Responsiveness in Severe Asthma
NCT00180661 ·Status: COMPLETED
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
NCT03128762 ·Status: COMPLETED
-
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
NCT06981169 ·Status: RECRUITING